Assyro AI

FDA Orange Book · active-ingredient family

Fludarabine phosphate

Fludarabine phosphate is approved as 3 brand and 10 generic applications in the FDA Orange Book, with their therapeutic-equivalence codes, listed patents, and marketing exclusivity.

3

Brand (NDA)

10

Generics (ANDA)

0

Listed patents

0

Exclusivity periods

Brand (NDA) products · injectable, tablet

ProductApplicantApplicationTEApproved
FLUDARABINE PHOSPHATERLDCAPLIN ONE LABSNDA 022137Sep 21, 2007
FLUDARARLDGENZYME CORPNDA 020038Apr 18, 1991
OFORTASANOFI AVENTIS USNDA 022273Dec 18, 2008

Generic (ANDA) products (10)

ProductApplicantApplicationTEApproved
FLUDARABINE PHOSPHATEACTAVIS LLCANDA 203738Feb 28, 2017
FLUDARABINE PHOSPHATERISINGANDA 200648Oct 16, 2012
FLUDARABINE PHOSPHATEEXTROVISANDA 200647Dec 21, 2011
FLUDARABINE PHOSPHATEAREVA PHARMSANDA 090724AP1Sep 27, 2010
FLUDARABINE PHOSPHATEACTAVIS TOTOWAANDA 078610APFeb 11, 2009
FLUDARABINE PHOSPHATEFRESENIUS KABI USAANDA 078393AP1Oct 15, 2007
FLUDARABINE PHOSPHATEFRESENIUS KABI USAANDA 078544APOct 15, 2007
FLUDARABINE PHOSPHATEHOSPIRAANDA 077790Apr 06, 2007
FLUDARABINE PHOSPHATESAGENT PHARMS INCANDA 076661AP1Apr 28, 2004
FLUDARABINE PHOSPHATEHIKMAANDA 076349APAug 28, 2003

Listed patents

No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Fludarabine phosphate — frequently asked questions

Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.